Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AzentaFRA:BA3 -0.70%78 OCF Margin % is 1.72% as of Jun. 2026, which is 84% below its 10-year median of 10.73. GuruFocus rates FRA:BA3 with a GF Score™ of 78/100 and a GF Value™ of €45.14 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 813 Medical Devices & Instruments companies, Azenta ranks worse than 50.18% on this metric.
The historical rank and industry rank for Azenta's OCF Margin % or its related term are showing as below:
FRA:BA3'
s OCF Margin % Range Over the Past 10 Years
Min: -83.9 Med: 10.73 Max: 29.17
Current: 6.18
During the past 13 years, the highest OCF Margin % of Azenta was 29.17%. The lowest was -83.90%. And the median was 10.73%.
FRA:BA3's OCF Margin % is ranked worse than 50.18% of 813
companies
in the Medical Devices & Instruments industry
Industry Median: 6.2
vs FRA:BA3: 6.18
The historical data trend for Azenta's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:BA3 vs KMTS, STAA, BLFS: OCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Azenta's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Azenta OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Azenta's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Azenta's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Azenta (FRA:BA3) has a OCF Margin % of 1.72% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Azenta and its competitors. This is 84% below median its historical median of 10.73. According to the industry distribution chart, Azenta ranks #408 out of 813 companies in the Medical Devices & Instruments industry, placing it in the top 50.2%.
Is Azenta's OCF Margin % too high?
Azenta's current OCF Margin % of 1.72% is 84% below median its 10-year median of 10.73. The Medical Devices & Instruments industry median OCF Margin % is 6.20. Azenta's value of 1.72% is 72.3% below this industry median. Based on the distribution chart, Azenta ranks #408 out of 813 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Azenta has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Azenta's OCF Margin % compare to KMTS and STAA?
According to the Medical Devices & Instruments industry distribution chart, Azenta ranks #408 out of 813 companies for OCF Margin %. This places Azenta in the lower half of its industry. The industry median OCF Margin % is 6.20. Azenta's value of 1.72% is 72.3% below this benchmark. While the company's 10-year median is 10.73 vs. the industry median of 6.20, Azenta has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 6.20, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Azenta's current OCF Margin % of 1.72% is 72.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Azenta and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 6.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Azenta's current OCF Margin % is 1.72%, which is 84% below median its own 10-year median of 10.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Azenta stock overvalued right now?
Based on GuruFocus' analysis, Azenta (FRA:BA3) is currently considered Significantly Undervalued. The stock's GF Value™ is €45.14, compared to a current price of €28.40 — trading 37.1% below its estimated fair value. The current OCF Margin % is 1.72%, which is 84% below median its 10-year median of 10.73 and 72.3% below the Medical Devices & Instruments industry median of 6.20. Azenta's overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Azenta (FRA:BA3), the current OCF Margin % is 1.72% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Azenta (FRA:BA3) Overvalued in 2026?
Based on GuruFocus' analysis, Azenta stock appears to be undervalued.
The current stock price of €28.40 is trading 37.1% below its estimated GF Value™ of €45.14.
GuruFocus considers Azenta to be Significantly Undervalued.
Key valuation signals for FRA:BA3:
OCF Margin %: 1.72% (84% below median its 10-year median of 10.73)
GF Value™: €45.14 vs. price of €28.40 (37.1% below fair value)
Industry Position: 72.3% below the Medical Devices & Instruments median (#408 of 813)
No single metric tells the full story. See the FRA:BA3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.
78GF Score
Get the complete analysis for FRA:BA3
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:BA3 has been successfully added to your 
